Clinical trials open for enrollment are listed alphabetically. Click on the title to view the details. A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis. Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail Psoriasis Effects of TNF-Alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test Etanercept Plus UVB-311nm Phototherapy in Psoriasis Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis Primary UVB-311nm and Adalimumab in Psoriasis Patients PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept Safety and Efficacy of Infliximab in Palmoplantar Psoriasis Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy Study to Compare U0267 Foam Against Vehicle Foam in Subjects With Plaque-Type Psoriasis UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis
Clinical trials open for enrollment are listed alphabetically. Click on the title to view the details.
A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis. Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail Psoriasis Effects of TNF-Alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test Etanercept Plus UVB-311nm Phototherapy in Psoriasis Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis Primary UVB-311nm and Adalimumab in Psoriasis Patients PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept Safety and Efficacy of Infliximab in Palmoplantar Psoriasis Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy Study to Compare U0267 Foam Against Vehicle Foam in Subjects With Plaque-Type Psoriasis UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis
A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment
Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects
Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis.
Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail Psoriasis
Effects of TNF-Alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test
Etanercept Plus UVB-311nm Phototherapy in Psoriasis
Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis
Primary UVB-311nm and Adalimumab in Psoriasis Patients
PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept
Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis
Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy
Study to Compare U0267 Foam Against Vehicle Foam in Subjects With Plaque-Type Psoriasis
UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis
